Statement of Fiona Lai

CEO of Covex

Fioa Lai, CEO of Covex S.A.

Dear Sir / Madam,

Welcome and thank you for taking the time to visit our website.

It is a pleasure for me to have the opportunity to address you for the first time since China Pioneer Pharma Holdings Limited became the majority shareholder of Covex S.A. on 1st July 2014, after having made a significant investment in order to strengthen the latter’s equity solvency and to ensure that Covex’s ambitious plans regarding future development are achieved.

We have decided to acquire a stake in Covex for numerous reasons; from amongst them all, I consider particularly noteworthy:

  • Its high quality standard of European-manufactured products.
  • The level of expertise gained over 35 years in its specialised field of business.
  • Its customer base spread throughout more than 50 countries, and its extraordinary workforce.

I am confident these values will be reinforced by the fact that Covex now forms part of China Pioneer Pharma Holdings Limited, a group listed on the Hong Kong stock exchange (Stock Code 01345), and committed to providing its customers with the best service throughout the progressive growth of its business.

I hope you will accompany us in this new project, and share in the success that we are sure to attain together.

Yours faithfully,

Ms. Fiona Lai



This Web Site uses cookies to collect information that helps optimize your visit or access to the COVEX, S.A. website. You may allow or reject them, and you may also change your settings whenever you wish. You will find more information in our

Cookies policy

You may restrict, block or delete cookies from COVEX, S.A. Or any other web page, using your browser. In each browser the operation is different (the 'Help' function will show you how to do it.) Here we show the links where you can see how to configure blocking of the most common browsers:

Close configuration